Pat | Myocardial defect | Bypass grafts to | Injection location | MNC number | CD34+ cell fraction | Changes in viability |
---|---|---|---|---|---|---|
1 | Transmural | LAD, D, OM, RCA | Posterolateral | 4.2 × 107 | 1.41% | None |
2 | Non-transmural | LAD, OM1, OM2 | Anterior, apex | 0.8 × 107 | 1.42% | 75% |
3 | Transmural | LAD, D, RCA | Posterobasal | 20.4 × 107 | 1.42% | 75% |
4 | Transmural | LAD, D, OM1 | Posterobasal | 7.0 × 107 | 1.26% | None |
5 | Transmural | LAD, D, OM, RCA | Apex | 2.8 × 107 | 3.28% | None |
6 | Transmural | OM1, OM2 | Posterolateral | 7.6 × 107 | 1.94% | None |
7 | Non-transmural | LAD, OM, RCA | Posterior | 6.0 × 107 | 2.93% | None |